2002
DOI: 10.1016/s0968-0896(02)00258-4
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Structure–Activity Relationship of Diarylamide Derivatives as Selective Inhibitors of the Proliferation of Human Endothelial Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…But in the case of 2a and 2b, no substitution at X position, 3,4,5-trimethoxyphenyl substitution at the urea moiety enhanced the inhibitory activity and the selectivity as reported previ- ously. 8) So, the further modification was conducted based on 2d. Table 2 presents the result of the SAR study on the substituents at the urea moiety with the ethylene substitution at X position.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…But in the case of 2a and 2b, no substitution at X position, 3,4,5-trimethoxyphenyl substitution at the urea moiety enhanced the inhibitory activity and the selectivity as reported previ- ously. 8) So, the further modification was conducted based on 2d. Table 2 presents the result of the SAR study on the substituents at the urea moiety with the ethylene substitution at X position.…”
Section: Resultsmentioning
confidence: 99%
“…Table 2 presents the result of the SAR study on the substituents at the urea moiety with the ethylene substitution at X position. Considering the result of 2a and 2b, 8) we evaluated 2g that had the 3,4,5-trimethoxyphenyl group at the urea moiety like 2b. But in this case, contrary to our expectation, the trimethoxyphenyl substitution resulted in decreased the activity.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…One example is in a type of HIV protease inhibitor [143]. A drug known as Tranilast, N-(3,4-dimethoxycinnamoyl)-AA, an avenanthramide (see 2.1.3), was originally developed as an anti-allergy drug but it has since been shown to inhibit angiogenesis [144], an important phenomenon in cancer and other degenerative deceases. Very recently pyridine analogues of flufenamic acid (27) have been evaluated as anti cancer agents [145].…”
Section: Alkaloids Derived From Anthranilic Acidmentioning
confidence: 99%